Health Secretary Neil Gray has been criticised for posting about football and traffic lights on social media while failing to ...

Patients in Scotland can't get the treatment - which is available in England - despite manufacturers giving it away for free ...

Spain’s ARTHEx Biotech has developed a dual-mechanism approach to treating the most common adult-onset muscular dystrophy ... shortening patients’ life expectancy to under 60 years on average ...

The parents of an eight-year-old boy with Duchenne muscular dystrophy are pleading with doctors to give their son a drug that will prolong his life.

CureDuchenne, led by CEO Debra Miller, is at the forefront of research for Duchenne muscular dystrophy, which is a rare and fatal neuromuscular disease.

Wave Life Sciences’ experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, setting the stage for a new therapeutic option for patients with the rare disease.

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Wave Life Sciences’ experimental ...